5
#000000
#FFFFFF
For Immediate Release
August, 03 2009, 05:00pm EDT
Contact:
Heather Pilatic, Pesticide Action Network
heather@panna.org, cell: 415.694.8596
Paul S. Towers, Pesticide Watch
916.551.1883
Strawberry Pesticide Up for Debate
Legislature investigates methyl iodide, slated for use in California
SACRAMENTO, Calif.
In a letter authored by Senator Mark Leno and Assemblymember Bill Monning, and signed by twenty-five state legislators, the signatories called on Governor Schwarzenegger to keep the controversial pesticide methyl iodide out of California's strawberry fields.
"We strongly believe that methyl iodide has no role to play in building a secure, viable and healthy agricultural economy in the 21st Century," said authors Senator Leno and Assemblymember Monning. On August 19, the Assembly Labor and Employment Committee will meet to explore the approval of methyl iodide and the potential impact on workers.
"While I am encouraged at the decision of DPR to pursue the external peer review and public testimony, I still believe it is imperative to devote a special informational hearing by the Assembly Labor and Employment Committee focused on worker health and safety issues related to the potential registration of Methyl Iodide," said Assemblymember Monning.
"We are pleased that this group of legislators is taking the lead to protect public health. The scientific review of methyl iodide is very important in this case because of the sheer number of hazards it poses--cancer, thyroid disease, miscarriages, and neurotoxicity. This highly politicized process needs a reality check that the scientific review will provide," said Dr. Susan Kegley, consulting scientist for Pesticide Action Network of North America.
On July 29, responding to concerns that previously planned public and scientific process were subject to cancellation or postponement by the Governor's office, the Department of Pesticide Regulation (DPR) announced its intentions to proceed with an external scientific review of methyl iodide.
Highly toxic and with application rates of up to 175 pounds per acre, methyl iodide has been controversial from the time US EPA announced its intent to register this chemical for legal use as a pesticide. In 2007, US EPA fast-tracked the registration of methyl iodide (a Proposition 65 carcinogen) for use as a soil fumigant despite serious concerns raised by a group of over 50 eminent scientists, including five Nobel Laureates. These scientists sent a letter of concern to US EPA explaining, " Because of methyl iodide's high volatility and water solubility, broad use of this chemical in agriculture will guarantee substantial releases to air, surface waters and groundwater, and will result in exposures for many people. In addition to the potential for increased cancer incidence, US EPA's own evaluation of the chemical also indicates that methyl iodide causes thyroid toxicity, permanent neurological damage, and fetal losses in experimental animals." The letter concludes, "It is astonishing that the Office of Pesticide Programs (of US EPA) is working to legalize broadcast releases of one of the more toxic chemicals used in manufacturing into the environment."
If registered as a soil fumigant, methyl iodide would be applied primarily in California's strawberry fields before planting, and as a gas it would drift away from the application site, and expose neighboring residents and farmworkers in nearby fields. Methyl iodide is a threat to air and water supplies and has been linked to very serious illnesses including cancer, miscarriages, thyroid toxicity, and neurological problems.
The Assembly Committee on Labor and Employment will meet to discuss the approval of methyl iodide in California, as well exposure to workers at 1:30 p.m. on Wednesday, August 19, in Room 447 of the California State Capitol.
PANNA (Pesticide Action Network North America) works to replace pesticide use with ecologically sound and socially just alternatives. As one of five autonomous PAN Regional Centers worldwide, we link local and international consumer, labor, health, environment and agriculture groups into an international citizens' action network. This network challenges the global proliferation of pesticides, defends basic rights to health and environmental quality, and works to ensure the transition to a just and viable society.
LATEST NEWS
‘Grossly Irresponsible’: $1.5 Trillion Trump Military Budget Would Explode Debt by $7 Trillion
"The truth is, there are not enough factories, or skilled workers, or materials to effectively spend such a huge increase," said one expert. "It will be a recipe for waste, fraud, and abuse."
Apr 03, 2026
The budget document that President Donald Trump's White House is set to release Friday calls for $1.5 trillion in military spending for the coming fiscal year, an unprecedented sum that—if approved by Congress—would add nearly $7 trillion to the US national debt over the next decade.
The Wall Street Journal's editorial board, which got an early look at the president's fiscal year 2027 budget, reported that the plan includes roughly $1.15 trillion in baseline US military spending as well as $350 billion in supplemental funding "that Republicans could pass in a party-line budget reconciliation bill." The Journal doesn't specify the purpose of the proposed supplemental funding, but the Pentagon has asked Congress for at least $200 billion for the Iran war.
The budget, which would boost total US military spending by more than 40% compared to the current fiscal year, also reportedly calls for investments in Trump's so-called Golden Dome missile defense system, a project that critics have derided as an absurd boondoggle.
Earlier this week, Trump suggested the US federal government can't afford to fund childcare and other domestic social programs because it is "fighting wars."
William Hartung, a senior research fellow at the Quincy Institute for Responsible Statecraft, wrote in an analysis of the budget proposal ahead of its official release that "whatever vehicles the administration chooses to promote this huge increase, it will be doubling down on a failed budgetary and national security strategy."
"If passed as requested, $1.5 trillion in Pentagon spending—in a single year–will make America weaker by underwriting a misguided strategy, funding outmoded weapons programs, and crowding out other essential public investments," Hartung argued. "The Pentagon doesn’t need more spending, it needs more spending discipline. Spending billions of dollars on a Golden Dome system that can never achieve the President’s dream of a leak-proof missile defense system is sheer waste, as is continuing to lavish funds on overpriced, underperforming combat aircraft like the F-35, or multi-billion dollar aircraft carriers that are vulnerable to modern high-speed missiles."
"The truth is, there are not enough factories, or skilled workers, or materials to effectively spend such a huge increase," he added. "It will be a recipe for waste, fraud, and abuse."
In anticipation of the White House proposal, a broad coalition of nearly 300 advocacy organizations sent a letter to members of Congress on Thursday demanding that they reject Trump's request and any other proposed budget increases for the Pentagon, which recently failed its eighth consecutive audit.
"We must invest in critical human needs programs in our communities. Instead, we have cut those programs massively," the groups wrote, pointing to the record Medicaid and nutrition assistance cuts that Trump and congressional Republicans approved last year.
"The Pentagon is unaccountable to American taxpayers, having never passed an audit, while more than half of its budget (54 percent) is paid to corporate military contractors, whose profits are rising. Further gigantic increases would be grossly irresponsible," the groups continued. "Funding an unaccountable Pentagon by more than $1 trillion while underfunding human needs programs undermines our security by preventing us from investing in the shared prosperity that comes from more housing, health care, climate and public health protections, ending hunger, and providing quality public education."
Keep Reading
Show Less
Trump Spews 'More Threats of War Crimes' as Iran Says It Shot Down US Fighter Jet
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," one analyst wrote of the Trump administration's assault.
Apr 03, 2026
US President Donald Trump late Thursday threatened more illegal attacks on Iranian civilian infrastructure, including bridges and power plants, as Iran's military said it shot down an American fighter jet over Tehran, with state-affiliated media publishing apparent photos from the scene.
An Iranian official told Drop Site's Jeremy Scahill that Iran's forces hit an F-15 warplane, causing the jet to crash and sparking "an intense fire." The unnamed Iranian official said the pilot could not have evacuated due to the "nature of the strike," but "no remains have yet been found."
The US Central Command had not commented on the purported downing of an American fighter jet as of this writing. Last month, a US F-35 was forced to make an emergency landing at an air base in the Middle East after reportedly being struck by Iranian fire.
🚨 BREAKING | An Iranian official told Drop Site News that a U.S. F-15 warplane struck by Iranian forces went down over southern Tehran Province, with intense fire reported at the crash site.
The official said the nature of the strike prevented the pilot[s] from ejecting before… https://t.co/iUKD0AqRQQ pic.twitter.com/BI4TzolmZY
— Drop Site (@DropSiteNews) April 3, 2026
Iran's claim on Friday came as Trump issued more belligerent threats on his social media platform, declaring that the US military "hasn’t even started destroying what’s left in Iran."
"Bridges next, then Electric Power Plants!" the president wrote, shortly after bragging about the US military's destruction of an Iranian highway bridge. "New Regime leadership knows what has to be done, and has to be done, FAST!"
Brian Finucane, senior adviser to the US Program at the International Crisis Group, characterized Trump's message as "more threats of war crimes as POTUS flails and seeks to coerce an exit to his own self-inflicted, unnecessary, and ill-conceived war."
Trump's renewed threats came amid reports of US-Israeli attacks on a century-old Iranian medical research center, pharmaceutical facilities, residential buildings, and other civilian infrastructure—and on emergency responders aiding those wounded by the attacks.
"War crime after war crime after war crime," US Rep. Yassamin Ansari (D-Ariz.), the lone Iranian American member of Congress, wrote early Friday. "Now’s the time to speak up if you’re against this reckless war of choice. The consequences will be vast and catastrophic."
Ben Rhodes, a political analyst who worked in the Obama administration, wrote that the US military's recent actions have "nothing to do with nuclear or helping Iranians."
"Just pointless forever war, death and destruction—a flailing, furious, rapidly declining superpower," Rhodes added.
Keep Reading
Show Less
Patient Advocates Warn Trump Pharma Tariffs Could 'Drive Up Costs and Create More Uncertainty'
One campaigner urged the administration to "focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."
Apr 02, 2026
On Thursday, the one-year anniversary of President Donald Trump's so-called Liberation Day, US advocacy groups sounded the alarm about his new tariffs targeting "patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act of 1962 to bolster American national security and public health."
The administration announced a year ago that the US Department of Commerce would conduct a related investigation under that law. The resulting report was recently sent to the president, and although the findings have not been made public, Trump's executive order summarizes key takeaways and Secretary Howard Lutnick's recommended actions.
According to the order, the secretary's recommendations included "continuing to negotiate onshoring agreements related to most favored nation (MFN) pharmaceutical pricing agreements; imposing significant tariffs on pharmaceuticals and pharmaceutical ingredients, so that such imports will not threaten to impair the national security of the United States; and granting preferential treatment to those companies that commit to onshore production of pharmaceuticals and pharmaceutical ingredients."
Citing an unnamed Trump administration official, The Washington Post reported Thursday that "the White House has reached agreements with 13 drugmakers and expects to soon conclude an additional four." As part of these deals, companies are planning to invest at least $400 billion in new US plants.
The Post also pointed out that "some imported drugs will face much lower tariffs under trade deals Trump negotiated with five US trading partners. Goods from the European Union, Japan, South Korea, and Switzerland will face 15% levies, while drugs from the United Kingdom, which was the first to sign a deal with Trump, will be hit with a 10% tariff."
Thanks to Trump's new order, brand-name pharmaceuticals made in other countries could be hit with tariffs as high as 100%.
Merith Basey, CEO of Patients for Affordable Drugs, warned in a statement that "while these tariffs aim to pressure pharmaceutical corporations into US manufacturing and most favored nation agreements, the current MFN deals remain opaque and voluntary, and have not delivered meaningful savings for the vast majority of American patients. There's a real risk these tariffs will drive up costs and create more uncertainty for millions of patients already struggling to afford their medications."
Experts at Public Citizen, another advocacy group that has sued to expose the secretive MFN agreements, were similarly critical.
"By announcing these tariffs without even producing the evidence from the investigation that supposedly justifies them, Trump is continuing his pattern of grabbing headlines by using the word 'tariff' while engaging in secretive ongoing negotiations and opaque exemptions processes that are ripe for corporate corruption," said Public Citizen Global Trade Watch director Melinda St. Louis—who also wrote a broader takedown of Trump's trade policy published Thursday by Common Dreams.
"While strategic tariffs can be used to support domestic manufacturing and good jobs, they must be paired with real public investments and support for workers' rights, which Trump has systematically undermined," she said. "Instead, he's bullying other countries like the UK into paying more for medicines, which will lead to windfall profits for Big Pharma and do nothing to reduce US prices."
Peter Maybarduk, director of Access to Medicines at Public Citizen, stressed that "Trump's tariffs will be either ineffective or harmful for what people need, which is a reliable, plentiful, affordable supply of medicine."
Also taking aim at the "secretive arrangements that allow Trump to claim specious victories on manufacturing and high drug prices," Maybarduk explained that "in reality, many manufacturing commitments claimed under the deals were part of previously planned projects and the drug pricing commitments appear designed to largely spare drug company profits rather than earnestly address affordability concerns."
"Meanwhile the administration has given drugmakers perks like lucrative vouchers to accelerate FDA review of their medicines and a promise from the Trump administration that it will bully other countries into adopting higher prescription drug prices, using tariffs as leverage," he continued, referring to the Food and Drug administration.
"If the administration wants to fix problems like medicines shortages and fragile supply chains," he argued, "it should focus on real solutions to support more transparent and diverse supply sources and make targeted investments for the supply of key medicines."
Keep Reading
Show Less
Most Popular